ID   PTK7_HUMAN              Reviewed;        1070 AA.
AC   Q13308; A8K974; B7Z477; E9PFZ5; Q13417; Q5T650; Q6IQ54; Q8NFA5; Q8NFA6;
AC   Q8NFA7; Q8NFA8;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   12-OCT-2022, entry version 208.
DE   RecName: Full=Inactive tyrosine-protein kinase 7;
DE   AltName: Full=Colon carcinoma kinase 4;
DE            Short=CCK-4;
DE   AltName: Full=Protein-tyrosine kinase 7;
DE   AltName: Full=Pseudo tyrosine kinase receptor 7;
DE   AltName: Full=Tyrosine-protein kinase-like 7;
DE   Flags: Precursor;
GN   Name=PTK7; Synonyms=CCK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon carcinoma, and Placenta;
RX   PubMed=7478540;
RA   Mossie K., Jallal B., Alves F., Sures I., Plowman G.D., Ullrich A.;
RT   "Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine
RT   kinase family.";
RL   Oncogene 11:2179-2184(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=8882711; DOI=10.1093/oxfordjournals.jbchem.a021228;
RA   Park S.-K., Lee H.-S., Lee S.-T.;
RT   "Characterization of the human full-length PTK7 cDNA encoding a receptor
RT   protein tyrosine kinase-like molecule closely related to chick KLG.";
RL   J. Biochem. 119:235-239(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS
RP   1; 2; 3; 4 AND 5).
RC   TISSUE=Testis;
RX   PubMed=12427550; DOI=10.1016/s0167-4781(02)00536-5;
RA   Jung J.-W., Ji A.-R., Lee J., Kim U.-J., Lee S.-T.;
RT   "Organization of the human PTK7 gene encoding a receptor protein tyrosine
RT   kinase-like molecule and alternative splicing of its mRNA.";
RL   Biochim. Biophys. Acta 1579:153-163(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 6).
RC   TISSUE=Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   GLYCOSYLATION AT ASN-646.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-646.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   FUNCTION.
RX   PubMed=18471990; DOI=10.1016/j.bbrc.2008.04.168;
RA   Shin W.-S., Maeng Y.-S., Jung J.-W., Min J.-K., Kwon Y.-G., Lee S.-T.;
RT   "Soluble PTK7 inhibits tube formation, migration, and invasion of
RT   endothelial cells and angiogenesis.";
RL   Biochem. Biophys. Res. Commun. 371:793-798(2008).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-116; ASN-175; ASN-268 AND
RP   ASN-283.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=20558616; DOI=10.1182/blood-2010-01-262352;
RA   Prebet T., Lhoumeau A.-C., Arnoulet C., Aulas A., Marchetto S.,
RA   Audebert S., Puppo F., Chabannon C., Sainty D., Santoni M.-J., Sebbagh M.,
RA   Summerour V., Huon Y., Shin W.-S., Lee S.-T., Esterni B., Vey N.,
RA   Borg J.-P.;
RT   "The cell polarity PTK7 receptor acts as a modulator of the
RT   chemotherapeutic response in acute myeloid leukemia and impairs clinical
RT   outcome.";
RL   Blood 116:2315-2323(2010).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION, CLEAVAGE, AND MUTAGENESIS OF
RP   LEU-622; MET-641 AND MET-701.
RX   PubMed=20837484; DOI=10.1074/jbc.m110.165159;
RA   Golubkov V.S., Chekanov A.V., Cieplak P., Aleshin A.E., Chernov A.V.,
RA   Zhu W., Radichev I.A., Zhang D., Dong P.D., Strongin A.Y.;
RT   "The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly
RT   efficient proteolytic target of membrane type-1 matrix metalloproteinase:
RT   implications in cancer and embryogenesis.";
RL   J. Biol. Chem. 285:35740-35749(2010).
RN   [14]
RP   FUNCTION.
RX   PubMed=21103379; DOI=10.1371/journal.pone.0014018;
RA   Meng L., Sefah K., O'Donoghue M.B., Zhu G., Shangguan D., Noorali A.,
RA   Chen Y., Zhou L., Tan W.;
RT   "Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis
RT   via mitochondrial pathway.";
RL   PLoS ONE 5:E14018-E14018(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION, INTERACTION WITH CTNNB1, AND REGION.
RX   PubMed=21132015; DOI=10.1038/embor.2010.185;
RA   Puppo F., Thome V., Lhoumeau A.-C., Cibois M., Gangar A., Lembo F.,
RA   Belotti E., Marchetto S., Lecine P., Prebet T., Sebbagh M., Shin W.-S.,
RA   Lee S.-T., Kodjabachian L., Borg J.-P.;
RT   "Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin
RT   canonical signalling.";
RL   EMBO Rep. 12:43-49(2011).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-276; SER-410; ASP-745; GLN-766;
RP   VAL-777; ARG-783; VAL-933; THR-1029 AND GLN-1038.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Inactive tyrosine kinase involved in Wnt signaling pathway.
CC       Component of both the non-canonical (also known as the Wnt/planar cell
CC       polarity signaling) and the canonical Wnt signaling pathway. Functions
CC       in cell adhesion, cell migration, cell polarity, proliferation, actin
CC       cytoskeleton reorganization and apoptosis. Has a role in embryogenesis,
CC       epithelial tissue organization and angiogenesis.
CC       {ECO:0000269|PubMed:18471990, ECO:0000269|PubMed:20558616,
CC       ECO:0000269|PubMed:20837484, ECO:0000269|PubMed:21103379,
CC       ECO:0000269|PubMed:21132015}.
CC   -!- SUBUNIT: Interacts with CTNNB1. {ECO:0000269|PubMed:21132015}.
CC   -!- INTERACTION:
CC       Q13308; P35222: CTNNB1; NbExp=5; IntAct=EBI-2803245, EBI-491549;
CC       Q13308; Q8IUG1: KRTAP1-3; NbExp=3; IntAct=EBI-2803245, EBI-11749135;
CC       Q13308; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-2803245, EBI-10171774;
CC       Q13308; Q99750: MDFI; NbExp=3; IntAct=EBI-2803245, EBI-724076;
CC       Q13308; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-2803245, EBI-11522433;
CC       Q13308; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-2803245, EBI-22310682;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:20837484}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:20837484}. Cell
CC       junction {ECO:0000269|PubMed:20837484}. Note=Colocalizes with MMP14 at
CC       cell junctions. Also localizes at the leading edge of migrating cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=PTK7-1;
CC         IsoId=Q13308-1; Sequence=Displayed;
CC       Name=2; Synonyms=PTK7-2;
CC         IsoId=Q13308-2; Sequence=VSP_037182;
CC       Name=3; Synonyms=PTK7-3;
CC         IsoId=Q13308-3; Sequence=VSP_037181;
CC       Name=4; Synonyms=PTK7-4;
CC         IsoId=Q13308-4; Sequence=VSP_037183;
CC       Name=5; Synonyms=PTK7-5;
CC         IsoId=Q13308-5; Sequence=VSP_037184, VSP_037185;
CC       Name=6;
CC         IsoId=Q13308-6; Sequence=VSP_044775;
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung, liver, pancreas, kidney,
CC       placenta and melanocytes. Weakly expressed in thyroid gland, ovary,
CC       brain, heart and skeletal muscle. Also expressed in erythroleukemia
CC       cells. But not expressed in colon.
CC   -!- INDUCTION: Higher expression in cell lines established from normal non-
CC       tumorigenic tissues compared to cell lines established from highly
CC       metastatic invasive carcinomas (at protein level).
CC       {ECO:0000269|PubMed:20837484}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- PTM: MMP14 cleaves PTK7 between Pro-621 and Leu-622 generating an N-
CC       terminal soluble (70 kDa) fragment and a membrane C-terminal (50 kDa)
CC       fragment. Proteolysis by MMP14 regulates PTK7 function in non-canonical
CC       Wnt signaling pathway. {ECO:0000269|PubMed:20837484}.
CC   -!- MISCELLANEOUS: [Isoform 5]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTK7ID41901ch6p21.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U33635; AAA87565.1; -; mRNA.
DR   EMBL; U40271; AAC50484.2; -; mRNA.
DR   EMBL; AF447176; AAL39062.1; -; Genomic_DNA.
DR   EMBL; AF447157; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447158; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447162; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447164; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447167; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447170; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447171; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447173; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447174; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447175; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF531868; AAN04862.1; -; mRNA.
DR   EMBL; AF531869; AAN04863.1; -; mRNA.
DR   EMBL; AF531870; AAN04864.1; -; mRNA.
DR   EMBL; AF531871; AAN04865.1; -; mRNA.
DR   EMBL; AF531872; AAN04866.1; -; mRNA.
DR   EMBL; AK291016; BAF83705.1; -; mRNA.
DR   EMBL; AK292589; BAF85278.1; -; mRNA.
DR   EMBL; AK296953; BAH12463.1; -; mRNA.
DR   EMBL; AL355385; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04154.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04155.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04156.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04158.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04160.1; -; Genomic_DNA.
DR   EMBL; BC071557; AAH71557.1; -; mRNA.
DR   CCDS; CCDS4884.1; -. [Q13308-1]
DR   CCDS; CCDS4885.1; -. [Q13308-2]
DR   CCDS; CCDS4886.1; -. [Q13308-3]
DR   CCDS; CCDS4887.1; -. [Q13308-4]
DR   CCDS; CCDS59021.1; -. [Q13308-6]
DR   PIR; JC4593; JC4593.
DR   RefSeq; NP_001257327.1; NM_001270398.1. [Q13308-6]
DR   RefSeq; NP_002812.2; NM_002821.4. [Q13308-1]
DR   RefSeq; NP_690619.1; NM_152880.3. [Q13308-2]
DR   RefSeq; NP_690620.1; NM_152881.3. [Q13308-3]
DR   RefSeq; NP_690621.1; NM_152882.3. [Q13308-4]
DR   PDB; 6VG3; X-ray; 1.95 A; A/B/C=774-1069.
DR   PDBsum; 6VG3; -.
DR   AlphaFoldDB; Q13308; -.
DR   SMR; Q13308; -.
DR   BioGRID; 111721; 113.
DR   IntAct; Q13308; 67.
DR   MINT; Q13308; -.
DR   STRING; 9606.ENSP00000418754; -.
DR   GlyConnect; 655; 40 N-Linked glycans (6 sites).
DR   GlyGen; Q13308; 11 sites, 7 Asn glycans (3 sites), 39 N-linked glycans (6 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q13308; -.
DR   MetOSite; Q13308; -.
DR   PhosphoSitePlus; Q13308; -.
DR   SwissPalm; Q13308; -.
DR   BioMuta; PTK7; -.
DR   DMDM; 116242736; -.
DR   EPD; Q13308; -.
DR   jPOST; Q13308; -.
DR   MassIVE; Q13308; -.
DR   MaxQB; Q13308; -.
DR   PaxDb; Q13308; -.
DR   PeptideAtlas; Q13308; -.
DR   PRIDE; Q13308; -.
DR   ProteomicsDB; 20212; -.
DR   ProteomicsDB; 59293; -. [Q13308-1]
DR   ProteomicsDB; 59294; -. [Q13308-2]
DR   ProteomicsDB; 59295; -. [Q13308-3]
DR   ProteomicsDB; 59296; -. [Q13308-4]
DR   ProteomicsDB; 59297; -. [Q13308-5]
DR   TopDownProteomics; Q13308-3; -. [Q13308-3]
DR   ABCD; Q13308; 1 sequenced antibody.
DR   Antibodypedia; 1008; 611 antibodies from 37 providers.
DR   DNASU; 5754; -.
DR   Ensembl; ENST00000230418.8; ENSP00000230418.4; ENSG00000112655.16. [Q13308-5]
DR   Ensembl; ENST00000230419.9; ENSP00000230419.4; ENSG00000112655.16. [Q13308-1]
DR   Ensembl; ENST00000345201.6; ENSP00000325992.4; ENSG00000112655.16. [Q13308-2]
DR   Ensembl; ENST00000349241.6; ENSP00000325462.4; ENSG00000112655.16. [Q13308-3]
DR   Ensembl; ENST00000352931.6; ENSP00000326029.3; ENSG00000112655.16. [Q13308-4]
DR   Ensembl; ENST00000481273.5; ENSP00000418754.1; ENSG00000112655.16. [Q13308-6]
DR   GeneID; 5754; -.
DR   KEGG; hsa:5754; -.
DR   MANE-Select; ENST00000230419.9; ENSP00000230419.4; NM_002821.5; NP_002812.2.
DR   UCSC; uc003oub.3; human. [Q13308-1]
DR   CTD; 5754; -.
DR   DisGeNET; 5754; -.
DR   GeneCards; PTK7; -.
DR   HGNC; HGNC:9618; PTK7.
DR   HPA; ENSG00000112655; Low tissue specificity.
DR   MIM; 601890; gene.
DR   neXtProt; NX_Q13308; -.
DR   OpenTargets; ENSG00000112655; -.
DR   PharmGKB; PA33961; -.
DR   VEuPathDB; HostDB:ENSG00000112655; -.
DR   eggNOG; KOG1026; Eukaryota.
DR   eggNOG; KOG4475; Eukaryota.
DR   GeneTree; ENSGT00940000157908; -.
DR   HOGENOM; CLU_012268_0_0_1; -.
DR   InParanoid; Q13308; -.
DR   OMA; MWWEHAG; -.
DR   OrthoDB; 530072at2759; -.
DR   PhylomeDB; Q13308; -.
DR   TreeFam; TF326835; -.
DR   PathwayCommons; Q13308; -.
DR   SignaLink; Q13308; -.
DR   SIGNOR; Q13308; -.
DR   BioGRID-ORCS; 5754; 19 hits in 1117 CRISPR screens.
DR   ChiTaRS; PTK7; human.
DR   GeneWiki; PTK7; -.
DR   GenomeRNAi; 5754; -.
DR   Pharos; Q13308; Tbio.
DR   PRO; PR:Q13308; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q13308; protein.
DR   Bgee; ENSG00000112655; Expressed in stromal cell of endometrium and 125 other tissues.
DR   ExpressionAtlas; Q13308; baseline and differential.
DR   Genevisible; Q13308; HS.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IBA:GO_Central.
DR   GO; GO:1904929; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0003401; P:axis elongation; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL.
DR   GO; GO:0090103; P:cochlea morphogenesis; IEA:Ensembl.
DR   GO; GO:0060026; P:convergent extension; IEA:Ensembl.
DR   GO; GO:0060976; P:coronary vasculature development; IEA:Ensembl.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0001736; P:establishment of planar polarity; IEA:Ensembl.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl.
DR   GO; GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 7.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   Pfam; PF07679; I-set; 3.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 7.
DR   SMART; SM00408; IGc2; 7.
DR   SUPFAM; SSF48726; SSF48726; 7.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 7.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Wnt signaling pathway.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..1070
FT                   /note="Inactive tyrosine-protein kinase 7"
FT                   /id="PRO_0000016748"
FT   TOPO_DOM        31..704
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        705..725
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        726..1070
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          31..120
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          128..218
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          225..317
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          309..407
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          412..497
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          503..586
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          578..680
FT                   /note="Ig-like C2-type 7"
FT   DOMAIN          796..1066
FT                   /note="Protein kinase; inactive"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          736..759
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          773..793
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          794..1070
FT                   /note="Interaction with CTNNB1"
FT                   /evidence="ECO:0000269|PubMed:21132015"
FT   SITE            621..622
FT                   /note="Cleavage; by MMP14"
FT   MOD_RES         1064
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BKG3"
FT   CARBOHYD        116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   CARBOHYD        175
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        214
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        268
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   CARBOHYD        283
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   CARBOHYD        405
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        463
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        567
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        646
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:19159218"
FT   DISULFID        53..101
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        150..200
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        246..301
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        343..391
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        433..481
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        524..570
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        613..664
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..26
FT                   /note="MGAARGSPARPRRLPLLSVLLLPLLG -> MGSFLSGEKRPSAPTVGSAMEK
FT                   KEFPTPPGRVGP (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044775"
FT   VAR_SEQ         410..540
FT                   /note="TVPSWLKKPQDSQLEEGKPGYLDCLTQATPKPTVVWYRNQMLISEDSRFEVF
FT                   KNGTLRINSVEVYDGTWYRCMSSTPAGSIEAQARVQVLEKLKFTPPPQPQQCMEFDKEA
FT                   TVPCSATGREKPTIKWERAD -> N (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12427550"
FT                   /id="VSP_037181"
FT   VAR_SEQ         500..539
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12427550,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037182"
FT   VAR_SEQ         627..682
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:12427550"
FT                   /id="VSP_037183"
FT   VAR_SEQ         804..816
FT                   /note="KSEFGEVFLAKAQ -> RPQAVPEDFQEQG (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12427550"
FT                   /id="VSP_037184"
FT   VAR_SEQ         817..1070
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12427550"
FT                   /id="VSP_037185"
FT   VARIANT         276
FT                   /note="R -> H (in dbSNP:rs56188167)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041502"
FT   VARIANT         410
FT                   /note="T -> S (in dbSNP:rs34021075)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041503"
FT   VARIANT         745
FT                   /note="E -> D (in dbSNP:rs9472017)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041504"
FT   VARIANT         766
FT                   /note="E -> Q (in dbSNP:rs56216742)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041505"
FT   VARIANT         777
FT                   /note="A -> V (in dbSNP:rs34764696)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041506"
FT   VARIANT         783
FT                   /note="H -> R (in dbSNP:rs55820547)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041507"
FT   VARIANT         933
FT                   /note="A -> V (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041508"
FT   VARIANT         1029
FT                   /note="P -> T (in dbSNP:rs55755163)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041509"
FT   VARIANT         1038
FT                   /note="R -> Q (in dbSNP:rs34865794)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041510"
FT   MUTAGEN         622
FT                   /note="L->D: Prevents proteolysis by MMP14."
FT                   /evidence="ECO:0000269|PubMed:20837484"
FT   MUTAGEN         641
FT                   /note="M->R: No impact on proteolysis by MMP14."
FT                   /evidence="ECO:0000269|PubMed:20837484"
FT   MUTAGEN         701
FT                   /note="M->D: No impact on proteolysis by MMP14."
FT                   /evidence="ECO:0000269|PubMed:20837484"
FT   CONFLICT        87
FT                   /note="F -> L (in Ref. 4; BAF85278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        92
FT                   /note="R -> P (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93
FT                   /note="L -> P (in Ref. 7; AAH71557)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        147
FT                   /note="T -> K (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        207
FT                   /note="G -> S (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        495..496
FT                   /note="RV -> VL (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        515
FT                   /note="E -> G (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        755
FT                   /note="Q -> R (in Ref. 4; BAH12463)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        799
FT                   /note="I -> F (in Ref. 4; BAF85278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        881
FT                   /note="G -> E (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        969
FT                   /note="P -> A (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        992
FT                   /note="F -> S (in Ref. 1; AAA87565)"
FT                   /evidence="ECO:0000305"
FT   HELIX           793..795
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          796..804
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          806..816
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          823..832
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           837..852
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          861..865
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          867..876
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          879..882
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           883..890
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           904..923
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           933..935
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          936..938
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          944..946
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   TURN            952..956
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           957..959
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          961..963
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   STRAND          966..968
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           970..972
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           975..980
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           985..1000
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   TURN            1006..1009
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           1012..1020
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           1034..1043
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           1048..1050
FT                   /evidence="ECO:0007829|PDB:6VG3"
FT   HELIX           1054..1062
FT                   /evidence="ECO:0007829|PDB:6VG3"
SQ   SEQUENCE   1070 AA;  118392 MW;  304926A1774EB5F4 CRC64;
     MGAARGSPAR PRRLPLLSVL LLPLLGGTQT AIVFIKQPSS QDALQGRRAL LRCEVEAPGP
     VHVYWLLDGA PVQDTERRFA QGSSLSFAAV DRLQDSGTFQ CVARDDVTGE EARSANASFN
     IKWIEAGPVV LKHPASEAEI QPQTQVTLRC HIDGHPRPTY QWFRDGTPLS DGQSNHTVSS
     KERNLTLRPA GPEHSGLYSC CAHSAFGQAC SSQNFTLSIA DESFARVVLA PQDVVVARYE
     EAMFHCQFSA QPPPSLQWLF EDETPITNRS RPPHLRRATV FANGSLLLTQ VRPRNAGIYR
     CIGQGQRGPP IILEATLHLA EIEDMPLFEP RVFTAGSEER VTCLPPKGLP EPSVWWEHAG
     VRLPTHGRVY QKGHELVLAN IAESDAGVYT CHAANLAGQR RQDVNITVAT VPSWLKKPQD
     SQLEEGKPGY LDCLTQATPK PTVVWYRNQM LISEDSRFEV FKNGTLRINS VEVYDGTWYR
     CMSSTPAGSI EAQARVQVLE KLKFTPPPQP QQCMEFDKEA TVPCSATGRE KPTIKWERAD
     GSSLPEWVTD NAGTLHFARV TRDDAGNYTC IASNGPQGQI RAHVQLTVAV FITFKVEPER
     TTVYQGHTAL LQCEAQGDPK PLIQWKGKDR ILDPTKLGPR MHIFQNGSLV IHDVAPEDSG
     RYTCIAGNSC NIKHTEAPLY VVDKPVPEES EGPGSPPPYK MIQTIGLSVG AAVAYIIAVL
     GLMFYCKKRC KAKRLQKQPE GEEPEMECLN GGPLQNGQPS AEIQEEVALT SLGSGPAATN
     KRHSTSDKMH FPRSSLQPIT TLGKSEFGEV FLAKAQGLEE GVAETLVLVK SLQSKDEQQQ
     LDFRRELEMF GKLNHANVVR LLGLCREAEP HYMVLEYVDL GDLKQFLRIS KSKDEKLKSQ
     PLSTKQKVAL CTQVALGMEH LSNNRFVHKD LAARNCLVSA QRQVKVSALG LSKDVYNSEY
     YHFRQAWVPL RWMSPEAILE GDFSTKSDVW AFGVLMWEVF THGEMPHGGQ ADDEVLADLQ
     AGKARLPQPE GCPSKLYRLM QRCWALSPKD RPSFSEIASA LGDSTVDSKP
//
